DXCM · 10-Q · 2026Q3 · Full report

Debt and Liquidity Position

DEXCOM INC · 2026-10-29 · Importance 7 · Surprise 6

Dexcom had outstanding senior convertible notes due in May 2028, with principal potentially convertible into cash and/or common shares before maturity if specified conditions are met. The company reported a debt-to-assets ratio of 0.20 at September 30, 2026. Its Credit Facility had no outstanding borrowings and $191.3 million available, with an $8.7 million letter-of-credit balance and a September 2031 maturity. Interest and principal on the 2028 Notes are identified as long-term liquidity requirements.

Key facts

• As of September 30, 2026, Dexcom had no outstanding Credit Facility borrowings, $8.7 million in outstanding letters of credit, and $191.3 million available for borrowing. source
• Dexcom's senior convertible notes classified as long-term mature in May 2028 and may be converted into cash and/or common shares before maturity once certain conditions are met. source
• Dexcom expects existing cash, short-term investments, and future operating cash flows generally to fund ongoing core business, but may need to access capital markets as borrowing sources become due or supplement internally generated cash for inorganic growth. source
• Dexcom's Credit Agreement matures in September 2031. source